Skip to main content
. 2023 Jan 17;13:1093607. doi: 10.3389/fimmu.2022.1093607

Figure 7.

Figure 7

(A) The scheme of CpG-SAV-exo to deliver APCs (Reprinted with the permission from Ref. 9); (B) The scheme of MHC-I positive exosomes for activating anti-tumor responses (Reprinted with the permission from Ref. 171). SAV; Streptavidin, SAV-LA; N-terminal secretion signal of lactadherin (LA) and C1C2 domain of LA.